A patient (32-year-old female) with Cushing's syndrome due to pituitary adenoma and hypertension with hypokalemia is reviewed. Endocrinological studies demonstrated low plasma renin activity, low plasma aldosterone concentration and high plasma deoxycorticosterone concentration. Blood pressure response to exogenousangiotensin II was enhanced. After the withdrawal of cortisol replacement following surgery, her abnormal endocrinological findings, hypertension and serum potassium level returned to normal and her blood pressure response to exogenous angiotensin II was reduced. These results suggest that in this case deoxycorticosterone might have contributed to the development and maintenance of her hypertension accompanied with hypokalemia. (Internal Medicine 32: 784-788, 1993) 
Introduction
It is widely recognized that hypertension is present in about 80%of cases of Cushing's syndrome (1) . There have been several hypotheses regarding high blood pressure, often accompanied by hypokalemia, observed in this syndrome. First, the overproduction of cortisol has been considered to induce these findings with its mineralocorticoid action (2), as well as its effect on hypertension by stimulating vascular sensitivity to catecholamines (3 , 4) . Second, deoxycorticosterone (DOC) and corticosterone in adrenal cancer and ectopic adrenocorticotrophic hormone (ACTH)syndrome have been supposed to contribute to the electrolytes disturbance and hypertension (5) . Third, other mineralocorticoids such as 1 7 alpha, 20 alpha-dihydroxyprogesterone, 17 alpha-hydroxyprogesterone (6) and 19-nordeoxycorticosterone (7) maycause the same symptoms. Last, enhanced production of plasma renin substrate by cortisol has been reported to elevate blood pressure through the reninangiotensin-aldosterone system (8) . Therefore, when discussing the genesis producing hypertension in Cushing's syndrome it must be taken into account whether mineralocorticoid actions play an important role in the development and maintenance of hypertension.
The patient presented here has Cushing's disease resulting from a pituitary adenoma, and has hypertension with low plasma renin activity (PRA), low plasma aldosterone concentration (PAC) and hypokalemia. Wediscuss the mechanism by which the hypertension was induced in this patient, compared with other forms of hypertension, including primary aldosteronism and Cushing's syndrome due to adrenocortical adenomaand pituitary adenoma.
Case Report A32-year-old womanconsulted our hospital for the evaluation of hypertension, truncal obesity and moonface. She had been aware of the obesity for about 10 years, when it had been pointed out by her parents. Several years after the first sign, she began to have intermittent headaches and palpitations. Acne on her face, petechiae on the extremities and then menopause occurred. Hypertension was first recognized when she consulted a nearby clinic complaining ofa headache. She had never taken any kind of drugs. There were no other members of the family with known or suspected hypertension. She had no previous serious disease. The physical examination on admission revealed that her weight was 53 kg and height 151 cm. Bloodpressure was 170/ 1 10 mmHgwith 72 bpm. Moonface, development of dorsal and supraclavicular fat pads and purpuric striae in lower extremities were also observed. ACTHand cortisol determined at 7:00 A.M. were 63 pmol/L (normal, 2-20) and 7,280 nmol/L (normal, 1 ,240-4, 140), which were constantly high without circadian changes. Twenty-four hour urinary excretion levels of 1 7-hydroxycorticosteroids and 17-ketosteroids were elevated to 41 jimol/d and 56 |imol/d, respectively. Administration of dexamethasone, 2 mg every six hours, instead of 0.5 mg every six hours, reduced the excretion of 17-hydroxycorticosteroids in 24-hour urine in three days. The bilateral exaggerated uptake of adosterol-13 1I was demonstrated with an adrenal scintigram. The skull X-ray films showedslight enlargement of the sella turcica. A diagnosis of Cushing's disease due to a pituitary tumor was madebased on these findings. The patient underwent selective adenomectomy with a transsphenoidal approach to confirm that the pituitary adenomawas producing excess amounts of ACTH. Immediately after surgery, replacement therapy with prednisolone, 30 mg, was begun, followed by decreasing doses until reaching zero six months later whenthe abnormal hormonelevels, including ACTH, cortisol, 17-hydroxycorticosteroids and 17-ketosteroids returned to within the normal ranges.
Methods of analysis of the cause ofhypertension in the present case Protocol 1. Measurement ofplasma renin activity, steroids, serumpotassium level and bloodpressure The present patient was placed on a 1 14 mmolsodium diet. Each blood sampling and blood pressure measurement was performed in the supine position while fasting in the morning.
Plasma cortisol, corticosterone, DOC and aldosterone concentration, and PRA were determined by radioimmunoassay (9, 10) . Serum potassium levels were determined with an autoanalyzer. These results were comparedwith those obtained nine months after the termination of the six-month glucocorticoid replacement therapy following surgery. Further, these data were comparedwith the results obtained from seven hypertensive patients with Cushing's syndrome due to adrenocortical adenoma, ranging from 26 to 53 years old, all female, whose accurate diagnosis was confirmed by the pathological findings of adrenal tumors taken surgically. Mean blood pressure was calculated using the formula: pulse pressure/3 + diastolic blood pressure. All data obtained fromcomparativegroups wereexpressed as the meardzSEM. Five patients with primary aldosteronism, ranging from 35 to 48 years old, 2 males and 3 females, and eight normal subjects, ranging from 25 to 56 years old, 4 males and4 females, served as comparative groups. Primary aldosteronism was diagnosed on the basis ofhypertension, continuous hypokalemia, low PRA, which was sustained by standing for 2 to 4 hours, and high aldosterone levels in plasma and urine. They were all hospitalized and had a diet containing 1 14 mmol sodium a day, and all drugs were withdrawnat least two weeks before each examination. Every examination was performed more than 30 minutes after the stabilization of blood pressure in the supine position in the morning while fasting. While monitoring blood pressure, angiotensin II dissolved in saline was infused intravenously at a dose of 1.0 ng/kg/min with a motor-driven syringe (NS-1, Natsume Seisakusho, Tokyo, Japan) and the dose was increased step-wise by accelerating the infusion rate every three to five minute until obtaining 20 mmHgrise in diastolic blood pressure. Finally, the exact dose of angiotensin II to raise the diastolic blood pressure by 20 mmHgwas calculated and defined as the required dose. Nine months after stopping the sixmonth glucocorticoid replacement therapy following surgery, this examination was repeated in the present patient.
Corticosterone andDOC responses to rapidACTHinfusion

Informed consent
Informed consent was obtained from all patients examined in this protocol.
Material
Angiotensin II was kindly provided by Ciba-Geigy (Basel, S witzerland). Cushing ' s syndrome due to adrenocortical adenoma. The present patient's surgery and the withdrawal of the six month postsurgery glucocorticoid replacement therapy normalized PRA and PAC to 0.52 ng/(L-s) and to 190 pmol/L, respectively (Fig.  1) . Plasma DOCof 1,810 pmol/L in this patient, which was higher than the mean of 710±250 pmol/L (ranging from 390 to 1 ,190) in Cushing's syndrome and the normal range (90-900) in our laboratory, decreased to 460 pmol/L at the termination of glucocorticoid replacement (Fig. 1, top left) . Plasma cortisol level in this patient was as high as that in Cushing's syndrome (730 vs 880+160 in nmol/L) and was lowered to 160 nmol/L by this therapy (Fig. 1 , bottom left) . The plasma corticosterone concentration in the present patient before and after treatment was 7,520 and 9,250 pmol/L, both of which were lower than the normal range in our laboratory (Fig. 1) . The mean blood pressure and serum potassium level in this patient were also restored from 128.0 to 100.0 mmHgand from 2.7 to 4.7 mmol/ L, respectively. On the other hand, those of the seven patients with Cushing's syndrome demonstrated 1 17.9+3.8 mmHgand 4.0±0.2 mmol/L, respectively (Fig. 1 , top and middle right).
Corticosterone andDOCresponses to rapidACTHinfusion
The baseline DOClevel in the present patient was higher than that in the other two patients with pituitary Gushing's disease. Meanwhile, there was not much difference in the baseline corticosterone level amongthe three patients. After the bolus ACTHinfusion, all three patients showed increased DOC and corticosterone concentrations in line with the time passed. However, DOCat each time in the present patient revealed a higher plasma concentration than that in the other two patients (Fig.2) . ment therapy, the blood pressure response to exogenous angiotensin II in the present patient was attenuated. The required dose returned to 19.5 ng/kg/min.
Discussion
The origins of Cushing's syndromeare heterogeneous. In ectopic ACTHsyndrome and adrenal cancer which induced Cushing ' s syndrome, Christy and Laragh (2) have reported that hypokalemic alkalosis is very closely correlated with plasma mineralocorticoids levels and is accompanied with hypertension due to the mineralocorticoid action of cortisol. Recently, Ulick and associates (12) also have reported that marked hypersecretion and incomplete peripheral metabolism of cortisol in ectopic ACTH syndrome are the predominant cause of mineralocorticoid-induced hypertension by cortisol itself. On the other hand, Schambelan and associates (5) have indicated that ectopic ACTH syndrome, as well as 17-hydroxylation deficiency syndrome, showed an increased production of DOC and corticosterone, potent mineralocorticoids. It has also been demonstrated that chronic ACTHstimulation in normal subjects increased production of DOCand corticosterone, additional to cortisol, but failed to stimulate aldosterone production (13) . Thus, the possibility has been raised that DOC and corticosterone overproduced by excess amountsof ACTH induce electrolyte imbalance and body fluid accumulation, and consequently produce hypertension. The present patient reported on here had Cushing's disease resulting from a pituitary adenoma; another type of Cushing's syndromedue to overproduced ACTH. Her plasma cortisol level as well as high blood pressure did not differ from that in the seven patients with adrenocortical adenoma, however, this level was not as high as that in ectopic ACTHsyndrome as indicated by Ulick and associates (12) , suggesting the lack of marked hypersecretion or incomplete peripheral metabolism of cortisol in pituitary Cushing's disease. Meanwhile, the serum potassium level in this patient had been lower than the mean of the other seven patients. Additionally, these seven patients demonstrated relatively high PRA, indicating the lack of mineralocorticoid action by cortisol at this level, which is as high as that in the present patient. Therefore, from these findings it seems unlikely that in the present patient the hypokalemia was caused by cortisol with its mineralocorticoid action.
On the other hand, the present patient showed a DOC In pituitary Cushing ' s disease, mineralocorticoid action, not by aldosterone or cortisol, but by other mineralocorticoids such as DOChave not been disclosed so far. To the best of our knowledge, this is the first patient with Cushing's syndrome resulting from pituitary adenoma in which mineralocorticoid action by DOCmight have played a partial role in contributing and maintaining hypertension with hypokalemia.
